Literature DB >> 28869892

Combination lung cancer chemotherapy: Design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin.

Shuang Li1, Lin Wang2, Na Li3, Yucai Liu1, Hui Su4.   

Abstract

The aim of the present study is to design a novel dual-ligand lipid based nanoparticle system. It is conducted by a specific ligand and pH sensitive lipid conjugate. Docetaxel (DTX) and baicalein (BA) are co-delivered by this system for combination lung cancer chemotherapy. Firstly, transferrin (Tf)-polyethylene glycol (PEG)-hydrazone (hz)-glyceryl monostearate (GMS), Tf-PEG-hz-GMS, was synthesized. Tf decorated DTX and BA loaded solid lipid nanoparticles (Tf-D/B-SLNs) were prepared by emulsification method. The capability of Tf-D/B-SLNs in suppressing lung cancer cells in vitro and in vivo was investigated. The results revealed the better antitumor efficiency of Tf-D/B-SLNs than the non-decorated SLNs and single drug loaded SLNs. Significant synergistic effects were observed in the dual drugs loaded systems. The best tumor inhibition ability and the lowest systemic toxicity also proved the pH-sensitive co-delivery nano-system could be a promising strategy for treatment of lung cancer.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Baicalin; Combination therapy; Docetaxel; Solid lipid nanoparticles; Transferrin; pH Sensitive

Mesh:

Substances:

Year:  2017        PMID: 28869892     DOI: 10.1016/j.biopha.2017.08.090

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  18 in total

1.  Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.

Authors:  Chengsong Cao; Qun Wang; Yong Liu
Journal:  Drug Des Devel Ther       Date:  2019-04-05       Impact factor: 4.162

2.  Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.

Authors:  Zhen Liang; Juan Li; Budong Zhu
Journal:  Drug Des Devel Ther       Date:  2020-10-27       Impact factor: 4.162

3.  Click-Ready Perfluorocarbon Nanoemulsion for 19F MRI and Multimodal Cellular Detection.

Authors:  Adam S Perez; Junhan Zhou; Benjamin Leach; Hongyan Xu; Deanne Lister; Stephen R Adams; Eric T Ahrens; Angelique Y Louie
Journal:  ACS Nanosci Au       Date:  2021-11-11

4.  Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.

Authors:  Yun Bian; Dong Guo
Journal:  Drug Des Devel Ther       Date:  2020-02-18       Impact factor: 4.162

5.  Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.

Authors:  Yonglong Jin; Yi Wang; Xiguang Liu; Jing Zhou; Xintong Wang; Hui Feng; Hong Liu
Journal:  Drug Des Devel Ther       Date:  2020-11-25       Impact factor: 4.162

6.  Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.

Authors:  Junjian Wang
Journal:  Drug Des Devel Ther       Date:  2020-02-26       Impact factor: 4.162

Review 7.  Smart Responsive Nanoformulation for Targeted Delivery of Active Compounds From Traditional Chinese Medicine.

Authors:  Xuejun Jiang; Mei Lin; Jianwen Huang; Mulan Mo; Houhe Liu; Yuan Jiang; Xiaowen Cai; Wingnang Leung; Chuanshan Xu
Journal:  Front Chem       Date:  2020-12-10       Impact factor: 5.221

8.  Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.

Authors:  Jicai Zhang; Xiang Xiao; Jianming Zhu; Ziyun Gao; Xianliang Lai; Xingen Zhu; Guohua Mao
Journal:  Int J Nanomedicine       Date:  2018-05-22

9.  Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers.

Authors:  He Bao; Nanbo Zheng; Zhuanting Li; Yuan Zhi
Journal:  Drug Des Devel Ther       Date:  2020-07-29       Impact factor: 4.162

10.  Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.

Authors:  Zhiyu Wang; Aimin Zang; Yaning Wei; Lin An; Dan Hong; Yan Shi; Jingnan Zhang; Shenyong Su; Guotao Fang
Journal:  Drug Des Devel Ther       Date:  2020-03-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.